ChromaDex

$3.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-2.12%) Today
$0.00 (0.00%) As of 4:30 PM EDT after-hours

Why Robinhood?

You can buy or sell ChromaDex and other stocks, options, ETFs, and crypto commission-free!

About CDXC

ChromaDex Corporation Common Stock, also called ChromaDex, is a nutraceutical company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. Read More The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer Products segment sells TRU NIAGEN to improve health by safely raising NAD levels. The Analytical Reference Standards and Services segment provides product regulatory approval and scientific advisory services to the clients in the food, supplement, and pharmaceutical industries. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Irvine, CA.

Employees
100
Headquarters
Los Angeles, California
Founded
1999
Market Cap
184.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
184.88K
High Today
$4.05
Low Today
$3.80
Open Price
$4.03
Volume
450.86K
52 Week High
$4.95
52 Week Low
$2.79

Collections

CDXC News

ReutersAug 15

Edited Transcript of CDXC earnings conference call or presentation 7-Aug-19 8:30pm GMT

3

CDXC Earnings

-$0.17
-$0.12
-$0.07
-$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours

More CDXC News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.